086450 — DongKook Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Market Cap
KR₩823bn
Enterprise Value
KR₩862bn
Revenue
KR₩731bn

Annual balance sheet for DongKook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	152,293	174,186	168,929	103,955	93,710
Net Total Accounts Receivable
Net Total Receivables	117,115	136,983	139,496	151,600	179,061
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	339,022	398,763	420,226	385,321	419,197
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	158,074	194,967	234,941	263,355	272,705
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	544,384	663,165	750,076	768,330	839,535
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	110,011	164,895	242,601	198,539	231,153
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	181,509	251,797	295,510	266,391	294,841
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	362,874	411,368	454,566	501,939	544,694
Total Liabilities & Shareholders' Equity	544,384	663,165	750,076	768,330	839,535
Total Common Shares Outstanding
Total Preferred Shares Outstanding